Showing 3,601 - 3,620 results of 9,305 for search 'significantly ((((lower decrease) OR (((we decrease) OR (nn decrease))))) OR (linear decrease))', query time: 0.42s Refine Results
  1. 3601
  2. 3602
  3. 3603
  4. 3604
  5. 3605
  6. 3606
  7. 3607
  8. 3608
  9. 3609
  10. 3610
  11. 3611
  12. 3612

    Table 1_Characteristics of myocardial work during exercise stress echocardiography in healthy adults.pdf by Liwei Huang (7165781)

    Published 2025
    “…</p>Results<p>GWI, GCW, and GWW increased, while GWE decreased after exercise. There were no significant differences in any of the global MW parameters between sexes at rest (all p > 0.05). …”
  13. 3613

    Image_1_Dietary soy protein reverses obesity-induced liver steatosis and alters fecal microbial composition independent of isoflavone level.JPEG by Reza Hakkak (11086)

    Published 2024
    “…</p>Results<p>Compared to CAS diet, feeding SPC-LIF and SPC-HIF diets resulted in significantly lower liver weight, liver steatosis score, and liver microvesicular score (p < 0.05), but did not lead to difference in body weight, liver macrovesicular score, serum ALT, or serum AST. …”
  14. 3614

    Table_1_Dietary soy protein reverses obesity-induced liver steatosis and alters fecal microbial composition independent of isoflavone level.DOCX by Reza Hakkak (11086)

    Published 2024
    “…</p>Results<p>Compared to CAS diet, feeding SPC-LIF and SPC-HIF diets resulted in significantly lower liver weight, liver steatosis score, and liver microvesicular score (p < 0.05), but did not lead to difference in body weight, liver macrovesicular score, serum ALT, or serum AST. …”
  15. 3615

    Table 2_Leptin: a gender and obesity-related marker predictive of metabolic comorbidities and therapeutic response to anti-IL-23 biologic drugs in psoriatic patients.docx by Roberta Belli (6939221)

    Published 2025
    “…Furthermore, in women, leptin levels were also associated with psoriatic arthritis, hypertension and, at lower extent, with type II diabetes. Finally, treatment with anti-IL-23 led to a reduction in visfatin levels in female psoriatic patients and resulted in a significant decrease in fat mass percentage in men. …”
  16. 3616

    Table 1_Leptin: a gender and obesity-related marker predictive of metabolic comorbidities and therapeutic response to anti-IL-23 biologic drugs in psoriatic patients.docx by Roberta Belli (6939221)

    Published 2025
    “…Furthermore, in women, leptin levels were also associated with psoriatic arthritis, hypertension and, at lower extent, with type II diabetes. Finally, treatment with anti-IL-23 led to a reduction in visfatin levels in female psoriatic patients and resulted in a significant decrease in fat mass percentage in men. …”
  17. 3617

    Table 3_Leptin: a gender and obesity-related marker predictive of metabolic comorbidities and therapeutic response to anti-IL-23 biologic drugs in psoriatic patients.docx by Roberta Belli (6939221)

    Published 2025
    “…Furthermore, in women, leptin levels were also associated with psoriatic arthritis, hypertension and, at lower extent, with type II diabetes. Finally, treatment with anti-IL-23 led to a reduction in visfatin levels in female psoriatic patients and resulted in a significant decrease in fat mass percentage in men. …”
  18. 3618

    Image 1_Leptin: a gender and obesity-related marker predictive of metabolic comorbidities and therapeutic response to anti-IL-23 biologic drugs in psoriatic patients.jpg by Roberta Belli (6939221)

    Published 2025
    “…Furthermore, in women, leptin levels were also associated with psoriatic arthritis, hypertension and, at lower extent, with type II diabetes. Finally, treatment with anti-IL-23 led to a reduction in visfatin levels in female psoriatic patients and resulted in a significant decrease in fat mass percentage in men. …”
  19. 3619

    <b>Global pattern and drivers of disease heterogeneity in aging populations</b> by Chengcheng Jin (20326186)

    Published 2024
    “…We observed significant geographic variations in disease heterogeneity, with higher SHDI values in high-income Western countries such as the United States of America and Sweden and lower in South Asia and Oceania (p < 0.05). …”
  20. 3620

    Image 2_Association of high consumption of soy products with the risk of cognitive impairment and major neurocognitive disorders: a systematic review and dose-response meta-analysi... by Jialin Yu (131558)

    Published 2025
    “…Risk data showed no significant association with cognitive impairment. Dose-response data further explained an inverse relationship between dose and risk of cognitive impairment, with higher doses associated with lower risk.…”